ArticleAMIA ... Annual Symposium proceedings. AMIA Symposium2024
Exploring the use of Artificial Genomes for Genome-wide Association Studies through the lens of Utility and Privacy.
Article in AMIA ... Annual Symposium proceedings. AMIA Symposium, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Advanced AI-Powered System for Comprehensive Thyroid Cancer Detection and Malignancy Risk Assessment.Life (Basel, Switzerland) · 2025Article
- Descriptor:IEEE data descriptions · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Collaborative Genome-wide association studies (GWAS) have the potential to uncover rare genetic variant-trait associations by leveraging larger datasets and diverse population samples. Despite this potential, privacy concerns and cumbersome review processes for data validation and collaborator selection hinder their broader implementation. Advances in generative models present a possible solution by generating synthetic datasets that closely resemble real genomic data, thus enhancing privacy and expediting the review process. This study assesses the capability of deep generative models to produce artificial genomic data for GWAS applications. We evaluate two state-of-the-art models on real-world datasets, identifying significant limitations in their ability to generate high-quality artificial genomes. Furthermore, we demonstrate that prevailing privacy measures, mainly based on membership inference attacks, are inadequate for providing insightful privacy evaluations. Our findings highlight the critical challenges and suggest future directions for the effective use of artificial genomes in GWAS.
Indexed as
Identifiers
40417560PMC12099349What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.